#AI Model #Bhutan #Viome #Gelephu

Viome Forms Strategic Partnership with Bhutan to Revolutionize Healthcare

In a groundbreaking collaboration, Viome Life Sciences has embarked on a significant journey with Bhutan's Druk Holding & Investments Ltd and Gelephu Mindfulness City. This partnership, formalized through a memorandum of understanding (MoU) signed in New York on September 25, 2026, aims to explore the development of an innovative Molecular Foundation Model that can revolutionize global diagnostics and drug development.

What is the Molecular Foundation Model?

The Molecular Foundation Model represents a sophisticated artificial intelligence system that processes large population-scale molecular data. This model generates a multitude of healthcare applications, from diagnostics to drug development. With capabilities to produce diagnostics from limited clinical samples and validate drug targets before extensive investments, this model notably accelerates the entire research and development cycle. By leveraging this technology, Viome and its partners aim to push the boundaries of biomedical research, potentially leading to significant breakthroughs in the medical field.

Naveen Jain, CEO of Viome Life Sciences, expressed enthusiasm for this collaboration, emphasizing the unique opportunity it provides. "We set out ten years ago to make illness optional by reading a person's biology in real time. Bhutan's clean energy and Gelephu Mindfulness City's regulatory freedom give us a place to build something we could not build inside an existing health system." This statement underscores a vision for the future of healthcare that prioritizes innovation and holistic wellbeing.

The Role of Bhutan

Bhutan brings a remarkable aspect to this partnership with its commitment to clean energy and the philosophy of Gross National Happiness. This development framework aims to prioritize human wellbeing and environmental sustainability in all aspects of progress. Ujjwal Deep Dahal, CEO of Druk Holding & Investments (DHI), reiterated that this collaboration is directly aligned with Bhutan’s broader goals, stating, "Our collaboration with Viome brings that philosophy together with frontier science, artificial intelligence, and precision health." He further aligned this effort with DHI 10X, a strategic initiative aimed at exponentially increasing Bhutan's economic contributions across various sectors, including technology and global investment.

Under this agreement, DHI is set to play a crucial role by funding and establishing a dedicated computational facility powered by the country's abundant hydropower. Gelephu Mindfulness City will serve as the regulatory and clinical environment where these innovations can be validated. This collaborative effort positions Bhutan as a burgeoning hub of biomedical research and health innovation.

Fostering Local Expertise

A pivotal aspect of this partnership is training local Bhutanese scientists and engineers at the planned Centre of Excellence. Guru Banavar, PhD, the founding head of Biomedical AI at Viome, highlighted the opportunity for knowledge transfer, stating, "Working with Viome can help Bhutan become a trusted global platform for preventive health and longevity research while delivering real improvements in our people's lives." This initiative showcases a commitment not only to advancing science but also to empowering local talent and fostering a culture of innovation.

Future Directions

The collaboration is set to undergo a pre-feasibility exercise in the upcoming weeks, culminating in an investment case and a phased technical plan. The integration of Viome's leading metatranscriptomic dataset into this promising research scenario further strengthens its potential. This overlap of data science, artificial intelligence, and healthcare positions all parties involved to explore uncharted territories in medical research.

As the partnership unfolds, experts are optimistic about the transformative impact this initiative may have, both for Bhutan and for the global healthcare landscape. By merging traditional Bhutanese values with cutting-edge technologies, this project aims to set a precedent for how emerging markets can harness innovation for public health enhancement on a global scale.

In conclusion, this collaboration stands as a testament to the potential of strategic partnerships that blend resources, knowledge, and cultures in the pursuit of advancing healthcare solutions. As Viome continues its mission to make illness optional, the world watches closely to see how this initiative shapes the future of medical science and preventive health strategies.